China Universal Asset Management Company’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$188K	Buy	53,798 +5,021	+10%	+$18.1K	0.01%	357
2025 Q4	$167K	Sell	48,777 -3,604	-7%	-$16.1K	0.01%	366
2025 Q3	$263K	Sell	52,381 -7,568	-13%	-$33.4K	0.02%	307
2025 Q2	$206K	Buy	59,949 +178	+0.3%	+$443	0.02%	308
2025 Q1	$133K	Sell	59,771 -2,858	-5%	-$8.2K	0.01%	343
2024 Q4	$184K	Buy	62,629 +5,955	+11%	+$16.6K	0.02%	334
2024 Q3	$147K	Buy	56,674 +22,128	+64%	+$61.3K	0.02%	323
2024 Q2	$102K	Sell	34,546 -21,760	-39%	-$82.3K	0.01%	300
2024 Q1	$255K	Buy	56,306 +22,740	+68%	+$116K	0.03%	263
2023 Q4	$192K	Buy	33,566 +26,143	+352%	+$121K	0.04%	210
2023 Q3	$34.1K	Buy	7,423 +3,638	+96%	+$22.1K	0.01%	255
2023 Q2	$24.5K	Sell	3,785 -113	-3%	-$771	0.01%	248
2023 Q1	$29.4K	Buy	3,898 +992	+34%	+$9.01K	0.01%	185
2022 Q4	$29.4K	Buy	2,906 +236	+9%	+$2.73K	0.01%	156
2022 Q3	$26K	Buy	+2,670	New	+$29.3K	0.01%	142